![Teresa Isele](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Teresa Isele
Algemeen Directeur bij Rhenman & Partners Asset Management AB
Vermogen: 4 775 $ op 31-05-2024
Profiel
Ms. Teresa Isele is a Chief Executive Officer at Rhenman & Partners Asset Management AB and an Independent Director at Aros Bostadsutveckling AB.
She is on the Board of Directors at Aros Bostadsutveckling AB.
She is with the firm since 2023.
She has law degrees from Humboldt Universität zu Berlin and Stockholm University, a master’s degree in international Commercial Arbitration from Stockholm University, as well as a Diploma in English Legal Studies from Kings College, London.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
0.00% | 31-12-2022 | 1 800 ( 0.00% ) | 4 775 $ | 31-05-2024 |
Actieve functies van Teresa Isele
Bedrijven | Functie | Begin |
---|---|---|
Rhenman & Partners Asset Management AB
![]() Rhenman & Partners Asset Management AB Investment ManagersFinance Rhenman & Partners Asset Management AB (Rhenman & Partners) is an independent Swedish alternative investment management firm which was founded in 2008 by a group of senior asset management industry executives including Henrik Rhenman and Göran Nordström. Headquartered in Stockholm, the firm is exclusively focused on the healthcare sector and manages the Rhenman Healthcare Equity L/S Fund, supported by a Scientific Advisory Board with a network of scientists and experts at renowned scientific institutions, including the Karolinska Institute and the University of Uppsala. | Algemeen Directeur | 01-03-2023 |
Eerdere bekende functies van Teresa Isele
Bedrijven | Functie | Einde |
---|---|---|
Swedsec Licensiering AB
![]() Swedsec Licensiering AB Miscellaneous Commercial ServicesCommercial Services Swedsec Licensiering AB is a Swedish company that focuses on strengthening competence and customer protection in the financial industry. The private company's licensing has been a cornerstone of this effort since its inception. Agneta Oscarsson has been the CEO of the company since 2023. | Algemeen Directeur | 28-02-2023 |
AROS BOSTADSUTVECKLING AB | Directeur/Bestuurslid | - |
Opleiding van Teresa Isele
University of Stockholm | Graduate Degree |
Humboldt State University | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 3 |
---|---|
Aros Bostadsutveckling AB
![]() Aros Bostadsutveckling AB Real Estate DevelopmentFinance Aros Bostadsutveckling AB engages in the acquisition and development of real properties. It focuses on developing sustainable residential housing in Stockholm and Uppsala regions. The company was founded by Johan Arthur Gustavsson, Per Rutegård, and Samir Taha in 2016 and is headquartered in Stockholm, Sweden. | Finance |
Swedsec Licensiering AB
![]() Swedsec Licensiering AB Miscellaneous Commercial ServicesCommercial Services Swedsec Licensiering AB is a Swedish company that focuses on strengthening competence and customer protection in the financial industry. The private company's licensing has been a cornerstone of this effort since its inception. Agneta Oscarsson has been the CEO of the company since 2023. | Commercial Services |
Rhenman & Partners Asset Management AB
![]() Rhenman & Partners Asset Management AB Investment ManagersFinance Rhenman & Partners Asset Management AB (Rhenman & Partners) is an independent Swedish alternative investment management firm which was founded in 2008 by a group of senior asset management industry executives including Henrik Rhenman and Göran Nordström. Headquartered in Stockholm, the firm is exclusively focused on the healthcare sector and manages the Rhenman Healthcare Equity L/S Fund, supported by a Scientific Advisory Board with a network of scientists and experts at renowned scientific institutions, including the Karolinska Institute and the University of Uppsala. | Finance |